Insider Transactions in Q2 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,790
+9.17%
|
$46,740
$6.32 P/Share
|
|
Apr 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,685
-7.43%
|
$467,400
$40.8 P/Share
|
|
Apr 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,685
+12.6%
|
$70,110
$6.32 P/Share
|
|
Apr 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
1,301
-12.44%
|
$53,341
$41.25 P/Share
|
|
Apr 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
1,301
+11.06%
|
$28,622
$22.55 P/Share
|
|
Apr 15
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.85%
|
$86,000
$43.04 P/Share
|
|
Apr 15
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.13%
|
$14,000
$7.8 P/Share
|
|
Apr 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
4,500
-74.95%
|
$193,500
$43.41 P/Share
|
|
Apr 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.84%
|
$31,500
$7.8 P/Share
|
|
Apr 14
2021
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.03%
|
$88,000
$44.5 P/Share
|
|
Apr 14
2021
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.44%
|
$14,000
$7.8 P/Share
|
|
Apr 08
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.1%
|
$210,000
$42.94 P/Share
|
|
Apr 07
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,586
-5.08%
|
$150,612
$42.34 P/Share
|
|
Apr 07
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.14%
|
$205,000
$41.03 P/Share
|
|
Apr 07
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.34%
|
$410,000
$41.97 P/Share
|
|
Apr 07
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.32 P/Share
|
|
Apr 06
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.09%
|
$210,000
$42.21 P/Share
|
|
Apr 06
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$400,000
$40.95 P/Share
|
|
Apr 06
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.32 P/Share
|